Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease

被引:42
作者
Miklossy, J
Taddei, K
Suva, D
Verdile, G
Fonte, J
Fisher, C
Gnjec, A
Ghika, J
Suard, F
Mehta, PD
McLean, CA
Masters, CL
Brooks, WS
Martins, RN
机构
[1] Temple Univ, Ctr Neurovirol & Canc Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA
[2] Univ Western Australia, Dept Psychiat & Neurogenet, Hollywood Private Hosp, Nedlands, WA 6009, Australia
[3] CHU Vaudois, Univ Inst Pathol, Div Neuropathol, CH-1011 Lausanne, Switzerland
[4] CHU Vaudois, Dept Neurol, CH-1011 Lausanne, Switzerland
[5] Psychiat & Psychogeriatry Nant, CH-1804 Corsier Sur Vevey, Switzerland
[6] New York State Inst Basic Res Dev Disabil, Dept Immunol, Staten Isl, NY 10314 USA
[7] Univ Melbourne, Alfred Hosp, NHMRC Dementia Brain Bank, Melbourne, Vic 3010, Australia
[8] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[9] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[10] Univ Sydney, Ctr Educ & Res Ageing, Concord, NSW 2139, Australia
[11] Concord Repatriat Gen Hosp, Concord, NSW 2139, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
early-onset familial Alzheimer's disease; presenilin-1; mutation; tetraspasticity; pyramidal signs; motor dysfunction; primary motor cortex;
D O I
10.1016/S0197-4580(02)00192-6
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Mutations in the gene encoding presenilin 1 (PS-1) account for 50% of early-onset familial Alzheimer's disease (EOFAD) cases. In this study, we identified two missense mutations in the coding sequence of the presenilin (PS-1) gene in two EOFAD pedigrees. AD was confirmed in one pedigree by autopsy. Mutation analysis of PCR products amplified from genomic DNA templates showed two novel PS-1 mutations resulting in Gln222His and Tyr256Ser. The two novel mutations are located within predicted transmembrane domains five (TM-5) and six (TM-6), respectively, and are associated with very early ages of onset. The Tyr256Ser is associated with one of the youngest age of AD onset, 25 years, which is consistent with a drastic change in function of the altered PS-1 protein. A morphometric analysis of the cortical degenerative changes of the Tyr256Ser case, showed severe involvement of the primary motor cortex, which correlated well with the pyramidal changes, including tetraspasticity. Immunoblot analysis showed the Tyr256Ser case had the greatest expression of Abeta(1-40) and Abeta(1-42), which was confirmed by ELISA, compared to other PS-1 mutant FAD cases and age-matched controls and, thus, contributes to the severity of the disease pathology. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:655 / 662
页数:8
相关论文
共 34 条
[11]   DIAGNOSIS OF ALZHEIMERS-DISEASE [J].
KHACHATURIAN, ZS .
ARCHIVES OF NEUROLOGY, 1985, 42 (11) :1097-1104
[12]   Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype [J].
Kwok, JBJ ;
Taddei, K ;
Hallupp, M ;
Fisher, C ;
Brooks, WS ;
Broe, GA ;
Hardy, J ;
Fulham, MJ ;
Nicholson, GA ;
Stell, R ;
Hyslop, PHS ;
Fraser, PE ;
Kakulas, B ;
Clarnette, R ;
Relkin, N ;
Gandy, SE ;
Schofield, PR ;
Martins, RN .
NEUROREPORT, 1997, 8 (06) :1537-1542
[13]   Cotton wool plaques in non-familial late-onset Alzheimer disease [J].
Le, TV ;
Crook, R ;
Hardy, J ;
Dickson, DW .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (11) :1051-1061
[14]   The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology [J].
Lemere, CA ;
Lopera, F ;
Kosik, KS ;
Lendon, CL ;
Ossa, J ;
Saido, TC ;
Yamaguchi, H ;
Ruiz, A ;
Martinez, A ;
Madrigal, L ;
Hincapie, L ;
Arango, JCL ;
Anthony, DC ;
Koo, EH ;
Goate, AM ;
Selkoe, DJ ;
Arango, JCV .
NATURE MEDICINE, 1996, 2 (10) :1146-1150
[15]   Intracellular accumulation of detergent-soluble amyloidogenic Aβ fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice [J].
Li, QX ;
Maynard, C ;
Cappai, R ;
McLean, CA ;
Cherny, RA ;
Lynch, T ;
Culvenor, JG ;
Trevaskis, J ;
Tanner, JE ;
Bailey, KA ;
Czech, C ;
Bush, AI ;
Beyreuther, K ;
Masters, CL .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (06) :2479-2487
[16]   Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 [J].
Li, YM ;
Xu, M ;
Lai, MT ;
Huang, Q ;
Castro, JL ;
DiMuzio-Mower, J ;
Harrison, T ;
Lellis, C ;
Nadin, JL ;
Neduvelil, JG ;
Register, RB ;
Sardana, MK ;
Shearman, MS ;
Smith, AL ;
Shi, XP ;
Yin, KC ;
Shafer, JA ;
Gardell, SJ .
NATURE, 2000, 405 (6787) :689-694
[17]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[18]   Increased plasma amyloid β protein 1-42 levels in Down syndrome [J].
Mehta, PD ;
Dalton, AJ ;
Mehta, SP ;
Kim, KS ;
Sersen, EA ;
Wisniewski, HM .
NEUROSCIENCE LETTERS, 1998, 241 (01) :13-16
[19]   Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease [J].
Mehta, PD ;
Pirttilä, T ;
Mehta, SP ;
Sersen, EA ;
Aisen, PS ;
Wisniewski, HM .
ARCHIVES OF NEUROLOGY, 2000, 57 (01) :100-105
[20]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MIRRA, SS ;
HEYMAN, A ;
MCKEEL, D ;
SUMI, SM ;
CRAIN, BJ ;
BROWNLEE, LM ;
VOGEL, FS ;
HUGHES, JP ;
VANBELLE, G ;
BERG, L .
NEUROLOGY, 1991, 41 (04) :479-486